A Simple Dosing Scheme for Intravenous Busulfan Based on Retrospective Population Pharmacokinetic Analysis in Korean Patients

Busulfan is an antineoplastic agent with a narrow therapeutic window. A post-hoc population pharmacokinetic analysis of a prospective randomized trial for comparison of four-times daily versus once-daily intravenous busulfan was carried out to search for predictive factors of intravenous busulfan (i...

Descripción completa

Detalles Bibliográficos
Autores principales: Choe, Sangmin, Kim, Gayeong, Lim, Hyeong-Seok, Cho, Sang-Heon, Ghim, Jong-Lyul, Jung, Jin Ah, Kim, Un-Jib, Noh, Gyujeong, Bae, Kyun-Seop, Lee, Dongho
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Physiological Society and The Korean Society of Pharmacology 2012
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3419763/
https://www.ncbi.nlm.nih.gov/pubmed/22915993
http://dx.doi.org/10.4196/kjpp.2012.16.4.273

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3419763/
https://www.ncbi.nlm.nih.gov/pubmed/22915993
http://dx.doi.org/10.4196/kjpp.2012.16.4.273

Ejemplares similares